000 | 01119 a2200349 4500 | ||
---|---|---|---|
005 | 20250512093338.0 | ||
264 | 0 | _c19700701 | |
008 | 197007s 0 0 eng d | ||
022 | _a0140-6736 | ||
024 | 7 |
_a10.1016/s0140-6736(70)91210-9 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHunter, K R | |
245 | 0 | 0 |
_aAmantadine in parkinsonism. _h[electronic resource] |
260 |
_bLancet (London, England) _cMay 1970 |
||
300 |
_a1127-9 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAmantadine _xadverse effects |
650 | 0 | 4 |
_aChlorides _xtherapeutic use |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aParkinson Disease _xdrug therapy |
650 | 0 | 4 | _aPlacebos |
700 | 1 | _aStern, G M | |
700 | 1 | _aLaurence, D R | |
700 | 1 | _aArmitage, P | |
773 | 0 |
_tLancet (London, England) _gvol. 1 _gno. 7657 _gp. 1127-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(70)91210-9 _zAvailable from publisher's website |
999 |
_c4197467 _d4197467 |